Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genomic alterations and clinical outcomes in patients with dedifferentiated liposarcoma

4 Dec 2022

Abstract excerpt

PURPOSE: Patients with unresectable dedifferentiated liposarcoma (DDLPS) have poor overall outcomes. Few genomic alterations have been identified with limited therapeutic options. EXPERIMENTAL DESIGN: Patients treated at Levine Cancer Institute with DDLPS were identified. Next generation sequencing (NGS), immunohistochemistry (IHC), and fluorescence in situ hybridization (FISH) testing were performed on tumor...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiac tumors and thrombi
Share to Glioma Diagnosis and Treatment
Share to Sarcoma Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36464833
DOI: 10.1002/cam4.5502

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genomic alterations and clinical outcomes in patients with dedifferentiated liposarcomaPMID 36464833Read ↗

High amplification levels of MDM2 and CDK4 correlate with poor outcome in patients with dedifferentiated liposarcoma: A cytogenomic microarray analysis of 47 casesSemantic proximity Read ↗

Genomic profiling of dedifferentiated liposarcoma compared to matched well-differentiated liposarcoma reveals higher genomic complexity and a common origin.Semantic proximity Read ↗

Integrated Genomic and Transcriptomic Analysis Revealed Mutation Patterns of De-differentiated Liposarcoma and LeiomyosarcomaSemantic proximity Read ↗

Beyond targeting amplified MDM2 and CDK4 in well differentiated and dedifferentiated liposarcomas: From promise and clinical applications towards identification of progression driversSemantic proximity Read ↗

Integrated exome and RNA sequencing of dedifferentiated liposarcoma.Semantic proximity Read ↗

Genomic landscape of liposarcoma.Semantic proximity Read ↗

Integrated genomic and transcriptomic analysis revealed mutation patterns of de-differentiated liposarcoma and leiomyosarcoma.Semantic proximity Read ↗

Copy Number Losses Define Subgroups of Dedifferentiated Liposarcoma with Poor Prognosis and Genomic InstabilitySemantic proximity Read ↗

Degree of MDM2 Amplification Affects Clinical Outcomes in Dedifferentiated LiposarcomaSemantic proximity Read ↗

Frequent alterations and epigenetic silencing of differentiation pathway genes in structurally rearranged liposarcomas.Semantic proximity Read ↗

Update on genomic and molecular landscapes of well-differentiated liposarcoma and dedifferentiated liposarcoma.Semantic proximity Read ↗

Dedifferentiated LiposarcomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.